PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Company ReportsCollegium Pharmaceutical
Collegium Pharmaceutical(COLL)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Loading
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Plot placeholder
Mock data
Subscribe for the real data
Revenue by Drug
Loading
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
NucyntaTapentadol2008-11-202024-2028
Pain
XtampzaOxycodone2016-04-262024-2036
Pain
,
Fever
,
Postoperative pain
,
Alcoholism
,
Opioid-related disorders
,
Drug overdose
,
Juvenile arthritis
,
Menorrhagia
,
Ankylosing spondylitis
,
Rheumatoid arthritis
,
Inflammation
,
Osteoarthritis
,
Bursitis
,
Dysmenorrhea
,
Gout
,
Premenstrual syndrome
,
Rheumatic fever
,
Septic shock
,
Respiration disorders
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Oxycodone
healthy volunteers/patients
,
analgesia
,
back pain
,
low back pain
,
osteoarthritis
,
constipation
,
pain
,
opioid-induced constipation
,
spinal cord injuries
,
chronic pain
Aspartame
myelodysplastic syndromes
,
aplastic anemia
Phenylacetic acid
healthy volunteers/patients
,
knee osteoarthritis
,
hip osteoarthritis
,
actinic keratosis
,
keratosis
Hld200
attention deficit disorder with hyperactivity
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use